Rituximab as second-line therapy after new direct antiviral agents in peripheral neuropathy hepatitis c virus related: Always correct therapeutic approach?
Mauro E.
•
Passadore P.
•
Quartuccio L.
altro
Mazzaro C.
2020
Periodico
ACTA GASTRO-ENTEROLOGICA BELGICA
WOS
Archivio
Diritti
closed access